How many clinical trials are tracked of CFZ533?

7 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

CFZ533

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of CFZ533

7 trials tracked of CFZ533.

7Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 2 7

Phase 2 A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease Completed
Phase 2 CCFZ533X2201 - PoC Study in de Novo Renal Transplantation Completed
Phase 2 Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects Completed
Phase 2 Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome Completed
Phase 2 Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients Completed
Phase 2 Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. Completed

Show 1 more trials

Phase 2 Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.